(Q39455124)

12 September 2017

title

Silymarin inhibits cervical cancer cell through an increase of phosphatase and tensin homolog (English)

1 reference

12 September 2017

main subject

cervix uterine cancer

1 reference

Hann-Chin Yu

1

1 reference

12 September 2017

Li-Jen Chen

2

1 reference

12 September 2017

Kai-Chun Cheng

3

1 reference

12 September 2017

Ying-Xiao Li

4

1 reference

12 September 2017

Ching-Hua Yeh

5

1 reference

12 September 2017

Juei-Tang Cheng

6

1 reference

12 September 2017

publication date

20 October 2011

1 reference

12 September 2017

published in

Phytotherapy Research

1 reference

12 September 2017

volume

26

1 reference

12 September 2017

issue

5

1 reference

12 September 2017

page(s)

709-715

1 reference

Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells

12 September 2017

cites work

1 reference

New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway

21 January 2018

1 reference

Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway

21 January 2018

1 reference

Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2.

21 January 2018

1 reference

Nuclear-cytoplasmic partitioning of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) differentially regulates the cell cycle and apoptosis

21 January 2018

1 reference

Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice

21 January 2018

1 reference

Nicotine inhibits human gingival fibroblast migration via modulation of Rac signalling pathways.

21 January 2018

1 reference

Silymarin in the treatment of chronic liver diseases: past and future

21 January 2018

1 reference

PI3K/Akt and apoptosis: size matters

21 January 2018

1 reference

Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.

21 January 2018

1 reference

Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies

21 January 2018

1 reference

Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas

21 January 2018

1 reference

Effects and mechanisms of silibinin on human hepatoma cell lines

21 January 2018

1 reference

The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells

21 January 2018

1 reference

Silymarin protects pancreatic beta-cells against cytokine-mediated toxicity: implication of c-Jun NH2-terminal kinase and janus kinase/signal transducer and activator of transcription pathways.

21 January 2018

1 reference

Therapeutic resistance resulting from mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR signaling pathways.

21 January 2018

1 reference

The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia

21 January 2018

1 reference

PTEN in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and cancer.

21 January 2018

1 reference

A coding-independent function of gene and pseudogene mRNAs regulates tumour biology

21 January 2018

1 reference

Caspases: intracellular signaling by proteolysis

21 January 2018

1 reference

Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion

21 January 2018

1 reference

A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer

21 January 2018

1 reference

Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas

21 January 2018

1 reference

Silibinin efficacy against human hepatocellular carcinoma

21 January 2018

1 reference

Drugging the PI3 kinome: from chemical tools to drugs in the clinic.

21 January 2018

1 reference

Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression

21 January 2018

1 reference

Chemopreventive effect of silymarin on liver pathology in HBV X protein transgenic mice

21 January 2018

1 reference

Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway.

21 January 2018

1 reference

Silibinin protects rat cardiac myocyte from isoproterenol-induced DNA damage independent on regulation of cell cycle.

21 January 2018

1 reference

21 January 2018

A Bad kinase makes good

1 reference

21 January 2018

Identifiers

DOI

10.1002/PTR.3618

1 reference

12 September 2017

1 reference